Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALLOGENE THERAPEUTICS, INC.

(ALLO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on ALLOGENE THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) ALLOGENE THERAPEUTICS, INC.
Analyst Recommendations on ALLOGENE THERAPEUTICS, INC.
01/03Guggenheim Adjusts Price Target for Allogene Therapeutics to $35 From $40, Maintains Buy R..
MT
2021RBC Cuts Price Target on Allogene Therapeutics to $35 From $45 Amid 'Mixed' Data, Keeps Ou..
MT
2021ALLOGENE THERAPEUTICS : Cowen Starts Allogene Therapeutics at Outperform
MT
2021ALLOGENE THERAPEUTICS : JMP Securities Adjusts Allogene Therapeutics' Price Target to $27 from $53, Keeps Market O..
MT
2021ALLOGENE THERAPEUTICS : SMBC Nikko Initiates Coverage on Allogene Therapeutics With Outperform Rating, $42 Price T..
MT
2021ALLOGENE THERAPEUTICS : Roth Capital Adjusts Allogene Therapeutics PT to $35 From $60, Maintains Buy Rating
MT
2021ALLOGENE THERAPEUTICS : Oppenheimer Adjusts Allogene Therapeutics PT to $40 From $44, Maintains Outperform Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 11,36 $
Average target price 32,38 $
Spread / Average Target 185%
High Price Target 55,00 $
Spread / Highest target 384%
Low Price Target 14,00 $
Spread / Lowest Target 23,2%
Consensus detail
Consensus revision (last 18 months)